Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Infection-related morbidity in a large study of transplant non-eligible newly diagnosed myeloma patients treated with UK standard of care.

Djebbari F, Panitsas F, Eyre TA, Prodger C, Davies F, Burton K, Khera A, Vallance G, Moore S, Kothari J, Peniket A, Ramasamy K.

Haematologica. 2020 Jan 9. pii: haematol.2019.240762. doi: 10.3324/haematol.2019.240762. [Epub ahead of print] No abstract available.

2.

Carfilzomib therapy for relapsed myeloma: results of a UK multicentre experience.

Djebbari F, Hubenov H, Neelakantan P, Wolf J, Offer M, Khera A, Louka E, Vallance G, Kothari J, Moore S, Ramasamy K.

Br J Haematol. 2020 Feb;188(4):e57-e60. doi: 10.1111/bjh.16324. Epub 2019 Dec 2. No abstract available.

PMID:
31792927
3.

Resource implications of bortezomib therapy in a large UK cohort: An evaluation study.

Djebbari F, Tatarczuch M, Panitsas F, Vallance G, Sultanova M, Kothari J, Ramasamy K, Peniket A.

J Oncol Pharm Pract. 2019 Dec;25(8):1995-1998. doi: 10.1177/1078155219866500. Epub 2019 Aug 7.

PMID:
31390961
4.

Clinical outcomes of bortezomib-based therapy in myeloma.

Djebbari F, Srinivasan A, Vallance G, Moore S, Kothari J, Ramasamy K.

PLoS One. 2018 Dec 12;13(12):e0208920. doi: 10.1371/journal.pone.0208920. eCollection 2018.

5.

Treat or palliate: outcomes of very elderly myeloma patients.

Panitsas F, Kothari J, Vallance G, Djebbari F, Ferguson L, Sultanova M, Ramasamy K.

Haematologica. 2018 Jan;103(1):e32-e34. doi: 10.3324/haematol.2017.173617. Epub 2017 Oct 12. No abstract available.

6.

A phase II trial of AZD1152 in relapsed/refractory diffuse large B-cell lymphoma.

Collins GP, Eyre TA, Linton KM, Radford J, Vallance GD, Soilleux E, Hatton C.

Br J Haematol. 2015 Sep;170(6):886-90. doi: 10.1111/bjh.13333. Epub 2015 Feb 26. No abstract available.

PMID:
25721307
7.

GATA1-mutant clones are frequent and often unsuspected in babies with Down syndrome: identification of a population at risk of leukemia.

Roberts I, Alford K, Hall G, Juban G, Richmond H, Norton A, Vallance G, Perkins K, Marchi E, McGowan S, Roy A, Cowan G, Anthony M, Gupta A, Ho J, Uthaya S, Curley A, Rasiah SV, Watts T, Nicholl R, Bedford-Russell A, Blumberg R, Thomas A, Gibson B, Halsey C, Lee PW, Godambe S, Sweeney C, Bhatnagar N, Goriely A, Campbell P, Vyas P; Oxford-Imperial Down Syndrome Cohort Study Group.

Blood. 2013 Dec 5;122(24):3908-17. doi: 10.1182/blood-2013-07-515148. Epub 2013 Sep 10.

8.

House dust mite control measures in the treatment of asthma.

Vallance G, McSharry C, Wood S, Thomson NC.

Ther Clin Risk Manag. 2006 Dec;2(4):347-54.

9.

Asthma: ten myths debunked.

Vallance G, Thomson NC.

Practitioner. 2004 Nov;248(1664):844-7. Review. No abstract available.

PMID:
15543882
10.

Students conducting consultations in general practice and the acceptability to patients.

Bentham J, Burke J, Clark J, Svoboda C, Vallance G, Yeow M.

Med Educ. 1999 Sep;33(9):686-7.

PMID:
10476020

Supplemental Content

Loading ...
Support Center